Posts in tag

hepatitis C


Drugs to treat Hepatitis C have cost the taxpayer more than $1 billion in 2018, and have topped the list of drugs ranked by cost to government in 2017-18 NPS …

Expensive medicines used to treat hepatitis C have cost the government more than any other drugs over the past year New figures based on PBS and RPBS scripts for the …

For the most part, it’s been a positive week in Australian pharmacy The Pharmaceutical Society’s conference, PSA17, has seen a number of positive announcements made: Health Minister Greg Hunt declared …

Hepatitis Australia has welcomed today’s announcement that a new hepatitis C drug will be listed on the PBS Epclusa, the first pan-genotypic antiviral, will be PBS listed from 1 August, …

We have one of the most comprehensive national hepatitis programs in the Asia-Pacific, survey finds The Asia Pacific Viral Hepatitis Policy Survey released this week has revealed how prepared different governments …

The new antivirals mean Australia is on track to eradicate hepatitis C, says one expert Associate Professor Simone Strasser, gastroenterologist at Royal Prince Alfred Hospital in Sydney, says the country …

More Australians were treated for hep C since DAAs were added to the PBS than in the past decade, according to new report Since direct-acting antiviral (DAA) hepatitis C treatments …

The first and only one-tablet, once-a-day treatment for all genotypes of chronic hepatitis C infection has been recommended for PBS listing Gilead Sciences Australia has announced that the TGA has …

The hep C medicines have been associated with reactivation of the hep B virus, which can lead to liver failure and even death A TGA review has found evidence of …

The latest in research news, as gathered by Debbie Rigby Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis This article reviews the pharmacokinetic and pharmacodynamic properties …

Hep C program success “extraordinary”, Senate committee hears, but no mention of cost to pharmacy  However, there is no mention of the issue of the cost of supplying and stocking …

The TGA has registered a new treatment regimen for the treatment of chronic Hepatitis C. MSD announced that Zepatier (elbasvir/grazoprevir) with or without ribavirin has been registered by the TGA …